首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1402610

伴隨診斷市場：依技術類型、應用、最終用戶、地區

Companion Diagnostics Market, By Technology Type (Real Time-Polymerase Chain Reactions, Gene Sequencing, Fluorescence in situ Hybridization, and Others) By Application, By End User, By Region

出版日期: 2023年12月21日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2023年全球伴隨診斷市場規模為69.5億美元，預計2030年將達156.3億美元，2023年至2030年複合年成長率為12.3%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	69.5億美元
實際資料	2018-2021	預測期	2023-2030
預測期複合年成長率	12.30%	2030年市場規模預測	156.3億美元

圖 1. 2023 年伴隨診斷的全球市場佔有率(%)（依地區）

伴隨診斷是用於檢測患者特定生物標記或基因的醫療設備，可以幫助確定哪些患者最適合特定治療。這些診斷透過幫助醫生選擇適當的癌症和其他疾病的標靶治療，在個體化醫療保健中發揮重要作用。伴隨診斷測試評估生物標記的表達，例如參與患者對特定藥物反應的蛋白質、基因和染色體。透過分析此類生物標記的表達水平，這些測試可以幫助確定特定藥物對於患有特定疾病的特定患者或患者群體是否安全有效。這確保了只有合適的患者才能接受專門的治療，從而改善治療結果。

市場動態：

全球伴隨診斷市場的推動因素包括個人化醫療需求的不斷成長、分子診斷的成長、新的標靶治療和伴隨診斷的核准不斷增加、技術進步以及癌症和其他慢性病的流行和流行。在費率方面。然而，這些分子診斷測試的開發和商業化面臨高昂的價格壓力和監管麻煩，這可能會限制市場成長。該市場的主要機會包括免疫治療生物標記和伴隨診斷的開發、非腫瘤疾病關鍵應用的開發以及體外診斷（IVD）公司和藥品製造商之間的精準醫療聯盟，更加關注伴隨診斷的開發新興市場的發展，以及採用次世代定序(NGS) 等先進技術進行生物標記檢測。

本研究的主要特點

本報告詳細分析了全球伴隨診斷市場，並列出了以2022年為基準年的預測期（2023-2030年）的市場規模。
本報告揭示了不同區隔市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
本報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
該報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球伴隨診斷市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
伴同性 Diagnostics 全球市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過分析全球伴隨診斷市場時所使用的各種策略矩陣，將有助於相關人員做出決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
北非
中部非洲

第9章競爭形勢

公司簡介
- F.Hoffmann-La Roche AG
- Agilent Technologies, Inc
- QIAGEN NV
- Abbott Laboratories, Inc.
- Almac Group
- Danaher Corporation
- Illumina, Inc
- bioMerieux SA
- Myriad Genetics, Inc
- Sysmex Corporation
- Thermo Fisher Scientific Inc
- Abnova Corporation
- Guardant Health, Inc.
- Icon Plc
- Biogenex Laboratories, Inc
分析師觀點

第10章

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI109

Global companion diagnostics market size is estimated to be valued at US$ 6.95 Bn in 2023 and is expected to reach US$ 15.63 Bn by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3 % from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 6.95 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	12.30%	2030 Value Projection:	US$ 15.63 Bn

Figure1. Global Companion Diagnostics Market Share (%), By Region, 2023

Companion diagnostics are medical devices that are used to detect specific biomarkers or genes in patients that help determine which patients are most suitable candidates for a particular therapy. These diagnostics play an important role in personalized healthcare by helping physicians select appropriate targeted treatment options for cancer and other diseases. Companion diagnostics tests evaluate the expression of biomarkers, such as proteins, genes or chromosomes that plays a role in a patient's response to a specific drug. By analyzing the expression levels of such biomarkers, these tests help to identify whether a particular drug would be safe and effective for a specific patient or set of patients with a given disease. This enables better therapeutic outcomes by ensuring only suitable patients receive specialized treatments.

Market Dynamics:

Global companion diagnostics market is driven by rising demand for personalized medicine, growth in molecular diagnostics, increasing approvals of new targeted therapies & companion diagnostics, technological advancements, and growing incidence and prevalence of cancer, and other chronic diseases. However, the market growth can be restricted by high pricing pressure and regulatory hassles that are involved in developing and commercializing these molecular diagnostic tests. Key opportunities in this market include developing biomarkers and companion diagnostics for immunotherapies, expanding applications in non-oncology diseases, precision medicine collaborations between In vitro diagnostics (IVD) companies and drug makers, growing focus on companion diagnostic development in emerging markets, and adoption of advanced technologies like Next-generation sequencing (NGS) for biomarker detection.

Key features of the study:

This report provides in-depth analysis of the global companion diagnostics market, and provides market size (US$ Bn)and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global companion diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Agilent Technologies, Inc., QIAGEN N.V, Abbott Laboratories, Inc., Almac Group, Danaher Corporation, Illumina, Inc., bioMerieux SA, Myriad Genetics, Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., Abnova Corporation, Guardant Health, Inc., Icon Plc., and Biogenex Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global companion diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion diagnostics market

Detailed Segmentation:

Global Companion Diagnostics Market, By Technology Type
- Real Time-Polymerase Chain Reactions (PCR
- Gene Sequencing
- Fluorescence in situ Hybridization
- Others
Global Companion Diagnostics Market, By Application
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Neurological Diseases
- Others
Global Companion Diagnostics Market, By End User
- Hospitals
- Research Laboratories
- Biopharmaceutical companies
- Others
Global Companion Diagnostics Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top Companies in Global Companion Diagnostics Market:
- F.Hoffmann-La Roche AG
- Agilent Technologies, Inc.
- QIAGEN N.V
- Abbott Laboratories, Inc.
- Almac Group
- Danaher Corporation
- Illumina, Inc.
- bioMerieux SA
- Myriad Genetics, Inc.
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Abnova Corporation
- Guardant Health, Inc.
- Icon Plc.
- Biogenex Laboratories, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Technology Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing number of cancer patients
- Complexity of Integration
- Emerging markets
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Companion Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Companion Diagnostics Market, By Technology Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Real Time-Polymerase Chain Reactions (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Gene Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Fluorescence in situ Hybridization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Companion Diagnostics Market, By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Neurological Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Companion Diagnostics Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Biopharmaceutical companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Companion Diagnostics Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
South Africa
North Africa
Central Africa